UP!

SCLN $11.15

SCLN target price
11.15
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2015-07-09 Downgrade BWS Financial Hold to Sell
2015-06-29 Initiated Coverage MLV & Co. Buy
2015-01-06 Reiterated Rating Aegis Positive
2014-12-19 Set Price Target Aegis Buy $10.00
2014-11-14 Downgrade BWS Financial Buy to Hold $8.25 to $8.00
2014-08-29 Reiterated Rating Aegis Buy
2013-11-12 Reiterated Aegis Capital Buy $9 to $8
2013-11-12 Lower Price Target Aegis Buy $9.00 to $8.00
2013-09-25 Reiterated Rating Aegis Buy
2013-07-16 Upgrade Aegis Capital Hold to Buy $9
2012-09-18 Upgrade BWS Financial Hold to Buy $8.25
2010-08-10 Downgrade BWS Financial Buy to Hold $7.25 to $4.50
2010-04-09 Upgrade BWS Financial Hold to Buy $7.25
2009-07-08 Downgrade BWS Financial Buy to Hold $3.25
2009-06-03 Initiated ThinkEquity Buy $5
2009-05-21 Initiated Rodman & Renshaw Mkt Outperform $5
2015-07-09 Downgrade BWS Financial Hold to Sell
2015-06-29 Initiated Coverage MLV & Co. Buy
2015-01-06 Reiterated Rating Aegis Positive
2014-12-19 Set Price Target Aegis Buy $10.00
2014-11-14 Downgrade BWS Financial Buy to Hold $8.25 to $8.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
CAVAZZA PAOLO 2.23%  (1141521) SCLN /
Rios Israel Chief Medical Officer 0.14%  (73750) SCLN /
WOODMAN DEAN S 0.14%  (70000) GPRO / HZO / SCLN /
Titus Gary Senior VP Finance & CFO 0.07%  (37095) ABIO / SCLN /
King Robert SVP of Prod. Dev/Supply Chain 0.03%  (16844) SCLN /